Non‐apoptotic regulated cell death mediates reprogramming of the tumour immune microenvironment by macrophages

Author:

Sun Chengpeng12,Zhan Jianhao2,Li Yao3,Zhou Chulin4ORCID,Huang Shuo4,Zhu Xingen1567,Huang Kai1567

Affiliation:

1. Department of Neurosurgery The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University Nanchang Jiangxi P. R. China

2. HuanKui Academy, Jiangxi Medical College, Nanchang University Nanchang Jiangxi China

3. The First Clinical Medical College, Jiangxi Medical College, Nanchang University Nanchang Jiangxi China

4. The Second Clinical Medical College, Jiangxi Medical College, Nanchang University Nanchang Jiangxi China

5. Institute of Neuroscience, Jiangxi Medical College, Nanchang University Nanchang Jiangxi P. R. China

6. Jiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases Nanchang China

7. JXHC Key Laboratory of Neurological Medicine Nanchang Jiangxi P. R. China

Abstract

AbstractTumour immune microenvironment (TIME) plays an indispensable role in tumour progression, and tumour‐associated macrophages (TAMs) are the most abundant immune cells in TIME. Non‐apoptotic regulated cell death (RCD) can avoid the influence of tumour apoptosis resistance on anti‐tumour immune response. Specifically, autophagy, ferroptosis, pyroptosis and necroptosis mediate the crosstalk between TAMs and tumour cells in TIME, thus reprogram TIME and affect the progress of tumour. In addition, although some achievements have been made in immune checkpoint inhibitors (ICIs), there is still defect that ICIs are only effective for some people because non‐apoptotic RCD can bypass the apoptosis resistance of tumour. As a result, ICIs combined with targeting non‐apoptotic RCD may be a promising solution. In this paper, the basic molecular mechanism of non‐apoptotic RCD, the way in which non‐apoptotic RCD mediates crosstalk between TAMs and tumour cells to reprogram TIME, and the latest research progress in targeting non‐apoptotic RCD and ICIs are reviewed.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangxi Province

Publisher

Wiley

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3